Huifan Ji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Huifan Ji has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Pujun Gao
Department of Hepatology, The First Hospital of Jilin University
2 shared publications - Xiaolin Guo
Department of Otolaryngology Head and Neck Surgery, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China
2 shared publications - Xu Li
Department of Hepatology, The First Hospital of Jilin University, Jilin University, No. 71 Xinmin Street, Changchun 130021, China
2 shared publications Bao-Rong Chi
The First Hospital of Jilin University
1 shared publication- Chang Li
State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonoses Prevention and Control, Academy of Military Medical Sciences, Changchun 130122, China
1 shared publication - Dong-Yun He
Department of Thoracic Oncology, The First Affiliated Hospital, Guangzhou Medical University, State Key Laboratory of Respiratory Diseases, National Clinical Research Center of Respiratory Disease, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 7 October 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-8
Relationships between Metabolic Comorbidities and Occurrence, Severity, and Outcomes in Patients with Acute Pancreatitis: A Narrative Review
Background. The population of patients with acute pancreatitis treated by the staff at our department of gastroenterology includes those with mild and self-limited disease ranging to those with severe and fatal disease. Early diagnosis and accurate prediction of the severity and outcome of this disease, which is commonly seen by our department, is important for a successful outcome. Metabolic comorbidities (e.g., diabetes mellitus, fatty liver, obesity, and metabolic syndrome) are relevant to the severity and progression of many diseases. The objective of this review was to examine clinical relationships between metabolic comorbidities and occurrence, severity, and outcome of acute pancreatitis.
- 7 October 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-8
Open AccessRelationships between Metabolic Comorbidities and Occurrence, Severity, and Outcomes in Patients with Acute Pancreatitis: A Narrative Review
Background. The population of patients with acute pancreatitis treated by the staff at our department of gastroenterology includes those with mild and self-limited disease ranging to those with severe and fatal disease. Early diagnosis and accurate prediction of the severity and outcome of this disease, which is commonly seen by our department, is important for a successful outcome. Metabolic comorbidities (e.g., diabetes mellitus, fatty liver, obesity, and metabolic syndrome) are relevant to the severity and progression of many diseases. The objective of this review was to examine clinical relationships between metabolic comorbidities and occurrence, severity, and outcome of acute pancreatitis.
- Open Access
- 31 January 2017
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-8
Gallstones in Patients with Chronic Liver Diseases
With prevalence of 10–20% in adults in developed countries, gallstone disease (GSD) is one of the most prevalent and costly gastrointestinal tract disorders in the world. In addition to gallstone disease, chronic liver disease (CLD) is also an important global public health problem. The reported frequency of gallstone in chronic liver disease tends to be higher. The prevalence of gallstone disease might be related to age, gender, etiology, and severity of liver disease in patients with chronic liver disease. In this review, the aim was to identify the epidemiology, mechanisms, and treatment strategies of gallstone disease in chronic liver disease patients.
- 31 January 2017
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-8
Open AccessGallstones in Patients with Chronic Liver Diseases
With prevalence of 10–20% in adults in developed countries, gallstone disease (GSD) is one of the most prevalent and costly gastrointestinal tract disorders in the world. In addition to gallstone disease, chronic liver disease (CLD) is also an important global public health problem. The reported frequency of gallstone in chronic liver disease tends to be higher. The prevalence of gallstone disease might be related to age, gender, etiology, and severity of liver disease in patients with chronic liver disease. In this review, the aim was to identify the epidemiology, mechanisms, and treatment strategies of gallstone disease in chronic liver disease patients.
- 28 March 2013
- Published by Springer Nature in Chemical Research in Chinese Universities
- Vol. 29 (2) , 270-274
Antitumor effects of Newcastle disease virus hemagglutinin-neuraminidase used as a molecular adjuvant
- 28 March 2013
- Published by Springer Nature in Chemical Research in Chinese Universities
- Vol. 29 (2) , 270-274
Antitumor effects of Newcastle disease virus hemagglutinin-neuraminidase used as a molecular adjuvant